Schell H, Duda G N, Peters A, et al. The haematoma and its role in bone healing [J]. J Exp Orthop, 2017, 4(1):5.
[2]
Dimitriou R, Jones E, Mc Gonagle D, et al. Bone regeneration: current concepts and future directions [J]. BMC Med, 2011, 9:66-76.
[3]
Mahajan A, Bhattacharyya S. Immunomodulation by mesenchymal stem cells during osteogenic differentiation: Clinical implications during bone regeneration [J]. Mol Immunol, 2023,164:143-152.
[4]
Sims N A, Martin T J. Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit [J].Bonekey Rep, 2014, 3:481.
[5]
Wang L, Li Y, Chen J, et al. Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture [J].Exp Hematol, 2002, 30(7):831-836.
[6]
Loi F, Córdova L A, Pajarinen J, et al. Inflammation, fracture and bone repair [J].Bone, 2016, 86(2):119- 130.
[7]
Myeroff C, Archdeacon M. Autogenous bone graft: donor sites and techniques [J]. J Bone Joint Surg Am, 2011, 93(23):2227-2236.
[8]
García-Gareta E, Coathup M J, Blunn G W. Osteoinduction of bone grafting materials for bone repair and regeneration [J]. Bone, 2015,81:112-121.
Ramaswamy R S H, Reddy R, Babu N C, et al. Stem-cell therapy and platelet-rich plasma in regenerative medicines: a review on pros and cons of the technologies[J].J Oral Maxillofac Pathol, 2018, 22(3):367- 374.
[11]
Franceschi R T. Biological approaches to bone regeneration by gene therapy [J].J Dent Res, 2005, 84 (12): 1093-1103.
[12]
Fiedler J, Etzel N, Brenner R E, et al. To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF [J]. J Cell Biochem, 2004,93(5):990-998.
[13]
Joyce M E, Roberts A B, Sporn M B, et al.Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur [J]. J Cell Biol. 1990,110(6):2195-2207.
[14]
Sarahrudi K,Thomas A, Mousavi M, et al. Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing [J]. Injury, 2011,42(8):833-837.
[15]
Song I W, Nagamani S C, Nguyen D, et al. Targeting TGF-βfor treatment of osteogenesis imperfecta [J]. J Clin Invest, 2022, 132(7). 13.
[16]
Velchev J D, Van Laer L, Luyckx I, et al. Loeys-dietz syndrome [J]. Adv Exp Med Biol, 2021, 1348:251-264.
[17]
Lieberman J R, Daluiski A, Einhorn T A. The role of growth factors in the repair of bone biology and clinical applications [J]. J Bone Joint Surg Am, 2002, 84(6):1032-1044.
[18]
Su P, Tian Y, Yang C, et al. Mesenchymal stem cell migration during bone formation and bone diseases therapy [J]. Int J Mol Sci, 2018,19(8):2343.
[19]
Sueyama Y, Kaneko T. Ito T, et al. Implantation of endothelial cells with mesenchymal stem cells accelerates dental pulp tissue regeneration/healing in pulpotomized rat molars [J]. J Endodont, 2017, 43 (6):943-948.
[20]
Hoogduijn M J, Popp F, Verbeek R, et al. The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy [J]. Int Immunopharmacol, 2010, 10(12):1496-1500.
[21]
Yu T, Pan H, Hu Y, et al. Autologous platelet-rich plasma induces bone formation of tissue engineered bone with bone marrow mesenchymal stem cells on beta-tricalcium phosphate ceramics [J]. J Orthop Surg Res, 2017, 12(1):178.
[22]
Wang X, Wang Y, Gou W, et al. Role of mesenchymal stem cells in bone regeneration and fracture repair: a review [J]. Int Orthop, 2013, 37(12):2491-2498.
[23]
Meiliana A, Dewi N, Wijaya A. Mesenchymal stem cells manage endogenous tissue regeneration [J]. Indones Biomed J, 2016, 8 (2) :71.
[24]
Subiran C, Kristensen S G, Andersen C Y. Umbilical cord blood-derived platelet-rich plasma: a clinically acceptable substitute for fetal bovine serum?[J] Fertil Steril, 2021, 115(2):336-337.
[25]
Lai F, Kakudo N, Morimoto N, et al. Preparing activated platelet-rich plasma for culturing human adipose-derived stem cells [J]. J Vis Exp, 2020, 159.
[26]
Santos Jr A, Sheguti T. Platelet-rich plasma (PRP) as an alternative to fetal bovine serum (FBS) in the culture of mesenchymal stem cells in cell therapy [J]. Stem Cell Res Ther, 2022, 7(1):26-28.
[27]
Sassoli C, Vallone L,Tani A, et al. Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration [J]. Cell Tissue Res, 2018, 372(3):549-570.
[28]
Zhao J, Liang G, Han Y, et al. Combination of mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) in the treatment of knee osteoarthritis: a meta-analysis of randomised controlled trials [J]. BMJ Open, 2022,12(11):e061008.
[29]
Han L, Fang W L, Jin B, et al. Enhancement of tendon-bone healing after rotator cuff injuries using combined therapy with mesenchymal stem cells and platelet rich plasma[J]. Eur Rev Med Pharmaco, 2019,23(20):9075-9084.
[30]
Alves R, Grimalt R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification [J]. Skin Appendage Disor, 2018,4(1):18-24.
[31]
Everts P, Onishi K, Jayaram P, et al. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020 [J]. Int J Mol Sci, 2020,21(20):7794.
[32]
Hudgens J L, Sugg K B, Grekin J A, et al. Platelet-rich plasma activates proinflammatory signaling pathways and induces oxidative stress in tendon fibroblasts [J]. Am J Sport Med, 2016, 44(8):1931-1940.
[33]
Infante A, Rubio-Azpeitia E, Sánchez P, et al. Platelet rich plasma and culture configuration affect the matrix forming phenotype of bone marrow stromal cells [J]. Tissue Eng Regen Med, 2017,14(5):567-577.
[34]
Fernandes G, Wang C, Yuan X, et al. Combination of controlled release platelet-rich plasma alginate beads and bone morphogenetic protein-2 genetically modified mesenchymal stem cells for bone regeneration [J]. J Periodontol, 2016, 87(4):470-480.
[35]
Andrew J G, Hoyland J A, Freemont A J, et al. Platelet-derived growth factor expression in normally healing human fractures [J]. Bone, 1995, 16(4):455-460.
[36]
Lai F, Kakudo N, Morimoto N, et al. Platelet-rich plasma enhances the proliferation of human adipose stem cells through multiple signaling pathways [J]. Stem Cell Res Ther, 2018,9(1):107.
[37]
Tobita M, Tajima S, Mizuno H. Adipose tissue-derived mesenchymal stem cells and platelet-rich plasma: stem cell transplantation methods that enhance stemness [J]. Stem Cell Res Ther, 2015, 6:215.
[38]
Jann J, Gascon S, Roux S, et al. Influence of the TGF-β superfamily on Osteoclasts/Osteoblasts balance in physiological and pathological bone conditions [J]. Int J Mol Sci, 2020, 21(20):7597.
[39]
Bastos R,Mathias M,Andrade R,et al. Intra-articular injections of expanded mesenchymal stem cells with and without addition of platelet-rich plasma are safe and effective for knee osteoarthritis [J]. Knee Surg Sport Tr A, 2018, 26(11): 3342-3350.
[40]
Silva D D D, Paz A H D R, Portinho C P, et al. Reconstruction of parietal bone defects with adiposederived mesenchymal stem cells. Experimental study [J]. Acta Cir Bras, 2021,35(12):e351201.
2025, Vol. 36 
